Abstract:
According to the WHO, as well as based on the publications presented on the
website of the electronic database of medical and biological publications «PubMed»,
there is an increase in the prevalence of diseases of the population suffering from
mental disorders of various degrees. Medicines of various pharmacological groups are
currently used to correct depressive disorders. Among such drugs, benzodiazepines, inhibitors of monoamine oxigenase, serotonin reuptake, and others, whose action is
aimed at various bonds of pathogenesis, are more often used. Among these mental
disorders, depressive and anxiety states predominate. All this reveals the need to find
and develop new approaches to the rational treatment of depressive disorders.
Medicinal products of synthetic origin occupy a significant place, but there are not so
many plant-based drugs, therefore the creation of new domestic medicinal products,
especially of plant origin, is an urgent task for modern pharmacy and medicine.
